Hubbry Logo
G0 phaseG0 phaseMain
Open search
G0 phase
Community hub
G0 phase
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
G0 phase
G0 phase
from Wikipedia
Mitosis in an animal cell (phases ordered counter-clockwise), with G0 labeled at left.
Many mammal cells, such as this 9x H neuron, remain permanently or semipermanently in G0.

The G0 phase describes a cellular state outside of the replicative cell cycle. Classically[when?], cells were thought to enter G0 primarily due to environmental factors, like nutrient deprivation, that limited the resources necessary for proliferation. Thus it was thought of as a resting phase. G0 is now known to take different forms and occur for multiple reasons. For example, most adult neuronal cells, among the most metabolically active cells in the body, are fully differentiated and reside in a terminal G0 phase. Neurons reside in this state, not because of stochastic or limited nutrient supply, but as a part of their developmental program.

G0 was first suggested as a cell state based on early cell cycle studies. When the first studies defined the four phases of the cell cycle using radioactive labeling techniques, it was discovered that not all cells in a population proliferate at similar rates.[1] A population's "growth fraction" – or the fraction of the population that was growing – was actively proliferating, but other cells existed in a non-proliferative state. Some of these non-proliferating cells could respond to extrinsic stimuli and proliferate by re-entering the cell cycle.[2] Early contrasting views either considered non-proliferating cells to simply be in an extended G1 phase or in a cell cycle phase distinct from G1 – termed G0.[3] Subsequent research pointed to a restriction point (R-point) in G1 where cells can enter G0 before the R-point but are committed to mitosis after the R-point.[4] These early studies provided evidence for the existence of a G0 state to which access is restricted. These cells that do not divide further exit G1 phase to enter an inactive stage called quiescent stage.

Diversity of G0 states

[edit]
Schematic karyogram of the human chromosomes, showing their usual state in the G0 and G1 phase of the cell cycle. At top center it also shows the chromosome 3 pair after having undergone DNA synthesis, occurring in the S phase (annotated as S) of the cell cycle. This interval includes the G2 phase and metaphase (annotated as "Meta.").

Three G0 states exist and can be categorized as either reversible (quiescent) or irreversible (senescent and differentiated). Each of these three states can be entered from the G1 phase before the cell commits to the next round of the cell cycle. Quiescence refers to a reversible G0 state where subpopulations of cells reside in a 'quiescent' state before entering the cell cycle after activation in response to extrinsic signals. Quiescent cells are often identified by low RNA content, lack of cell proliferation markers, and increased label retention indicating low cell turnover.[5][6] Senescence is distinct from quiescence because senescence is an irreversible state that cells enter in response to DNA damage or degradation that would make a cell's progeny nonviable. Such DNA damage can occur from telomere shortening over many cell divisions as well as reactive oxygen species (ROS) exposure, oncogene activation, and cell-cell fusion. While senescent cells can no longer replicate, they remain able to perform many normal cellular functions.[7][8][9][10] Senescence is often a biochemical alternative to the self-destruction of such a damaged cell by apoptosis. In contrast to cellular senescence, quiescence is not a reactive event but part of the core programming of several different cell types. Finally, differentiated cells are stem cells that have progressed through a differentiation program to reach a mature – terminally differentiated – state. Differentiated cells continue to stay in G0 and perform their main functions indefinitely.

Characteristics of quiescent stem cells

[edit]

Transcriptomes

[edit]

The transcriptomes of several types of quiescent stem cells, such as hematopoietic, muscle, and hair follicle, have been characterized through high-throughput techniques, such as microarray and RNA sequencing. Although variations exist in their individual transcriptomes, most quiescent tissue stem cells share a common pattern of gene expression that involves downregulation of cell cycle progression genes, such as cyclin A2, cyclin B1, cyclin E2, and survivin, and upregulation of genes involved in the regulation of transcription and stem cell fate, such as FOXO3 and EZH1. Downregulation of mitochondrial cytochrome C also reflects the low metabolic state of quiescent stem cells.[11]

Epigenetic

[edit]

Many quiescent stem cells, particularly adult stem cells, also share similar epigenetic patterns. For example, H3K4me3 and H3K27me3, are two major histone methylation patterns that form a bivalent domain and are located near transcription initiation sites. These epigenetic markers have been found to regulate lineage decisions in embryonic stem cells as well as control quiescence in hair follicle and muscle stem cells via chromatin modification.[11]

Regulation of quiescence

[edit]

Cell cycle regulators

[edit]

Functional tumor suppressor genes, particularly p53 and Rb gene, are required to maintain stem cell quiescence and prevent exhaustion of the progenitor cell pool through excessive divisions. For example, deletion of all three components of the Rb family of proteins has been shown to halt quiescence in hematopoietic stem cells. Lack of p53 has been shown to prevent differentiation of these stem cells due to the cells' inability to exit the cell cycle into the G0 phase. In addition to p53 and Rb, cyclin dependent kinase inhibitors (CKIs), such as p21, p27, and p57, are also important for maintaining quiescence. In mouse hematopoietic stem cells, knockout of p57 and p27 leads to G0 exit through nuclear import of cyclin D1 and subsequent phosphorylation of Rb. Finally, the Notch signaling pathway has been shown to play an important role in maintenance of quiescence.[11]

Post-transcriptional regulation

[edit]

Post-transcriptional regulation of gene expression via miRNA synthesis has been shown to play an equally important role in the maintenance of stem cell quiescence. miRNA strands bind to the 3′ untranslated region (3′ UTR) of target mRNAs, preventing their translation into functional proteins. The length of the 3′ UTR of a gene determines its ability to bind to miRNA strands, thereby allowing regulation of quiescence. Some examples of miRNA's in stem cells include miR-126, which controls the PI3K/AKT/mTOR pathway in hematopoietic stem cells, miR-489, which suppresses the DEK oncogene in muscle stem cells, and miR-31, which regulates Myf5 in muscle stem cells. miRNA sequestration of mRNA within ribonucleoprotein complexes allows quiescent cells to store the mRNA necessary for quick entry into the G1 phase.[11]

Response to stress

[edit]

Stem cells that have been quiescent for a long time often face various environmental stressors, such as oxidative stress. However, several mechanisms allow these cells to respond to such stressors. For example, the FOXO transcription factors respond to the presence of reactive oxygen species (ROS) while HIF1A and LKB1 respond to hypoxic conditions. In hematopoietic stem cells, autophagy is induced to respond to metabolic stress.[11]

Examples of reversible G0 phase

[edit]

Tissue stem cells

[edit]

Stem cells are cells with the unique ability to produce differentiated daughter cells and to preserve their stem cell identity through self-renewal.[12] In mammals, most adult tissues contain tissue-specific stem cells that reside in the tissue and proliferate to maintain homeostasis for the lifespan of the organism. These cells can undergo immense proliferation in response to tissue damage before differentiating and engaging in regeneration. Some tissue stem cells exist in a reversible, quiescent state indefinitely until being activated by external stimuli. Many different types of tissue stem cells exist, including muscle stem cells (MuSCs), neural stem cells (NSCs), intestinal stem cells (ISCs), and many others.

Stem cell quiescence has been recently suggested to be composed of two distinct functional phases, G0 and an 'alert' phase termed GAlert.[13] Stem cells are believed to actively and reversibly transition between these phases to respond to injury stimuli and seem to gain enhanced tissue regenerative function in GAlert. Thus, transition into GAlert has been proposed as an adaptive response that enables stem cells to rapidly respond to injury or stress by priming them for cell cycle entry. In muscle stem cells, mTORC1 activity has been identified to control the transition from G0 into GAlert along with signaling through the HGF receptor cMet.[13]

Mature hepatocytes

[edit]

While a reversible quiescent state is perhaps most important for tissue stem cells to respond quickly to stimuli and maintain proper homeostasis and regeneration, reversible G0 phases can be found in non-stem cells such as mature hepatocytes.[14] Hepatocytes are typically quiescent in normal livers but undergo limited replication (less than 2 cell divisions) during liver regeneration after partial hepatectomy. However, in certain cases, hepatocytes can experience immense proliferation (more than 70 cell divisions) indicating that their proliferation capacity is not hampered by existing in a reversible quiescent state.[14]

Examples of irreversible G0 phase

[edit]

Senescent cells

[edit]

Often associated with aging and age-related diseases in vivo, senescent cells can be found in many renewable tissues, including the stroma, vasculature, hematopoietic system, and many epithelial organs. Resulting from accumulation over many cell divisions, senescence is often seen in age-associated degenerative phenotypes. Senescent fibroblasts in models of breast epithelial cell function have been found to disrupt milk protein production due to secretion of matrix metalloproteinases.[15] Similarly, senescent pulmonary artery smooth muscle cells caused nearby smooth muscle cells to proliferate and migrate, perhaps contributing to hypertrophy of pulmonary arteries and eventually pulmonary hypertension.[16]

Differentiated muscle

[edit]

During skeletal myogenesis, cycling progenitor cells known as myoblasts differentiate and fuse together into non-cycling muscle cells called myocytes that remain in a terminal G0 phase.[17] As a result, the fibers that make up skeletal muscle (myofibers) are cells with multiple nuclei, referred to as myonuclei, since each myonucleus originated from a single myoblast. Skeletal muscle cells continue indefinitely to provide contractile force through simultaneous contractions of cellular structures called sarcomeres. Importantly, these cells are kept in a terminal G0 phase since disruption of muscle fiber structure after myofiber formation would prevent proper transmission of force through the length of the muscle. Muscle growth can be stimulated by growth or injury and involves the recruitment of muscle stem cells – also known as satellite cells – out of a reversible quiescent state. These stem cells differentiate and fuse to generate new muscle fibers both in parallel and in series to increase force generation capacity.

Cardiac muscle is also formed through myogenesis but instead of recruiting stem cells to fuse and form new cells, heart muscle cells – known as cardiomyocytes – simply increase in size as the heart grows larger. Similarly to skeletal muscle, if cardiomyocytes had to continue dividing to add muscle tissue the contractile structures necessary for heart function would be disrupted.

Differentiated bone

[edit]

Of the four major types of bone cells, osteocytes are the most common and also exist in a terminal G0 phase. Osteocytes arise from osteoblasts that are trapped within a self-secreted matrix. While osteocytes also have reduced synthetic activity, they still serve bone functions besides generating structure. Osteocytes work through various mechanosensory mechanisms to assist in the routine turnover over bony matrix.

Differentiated nerve

[edit]

Outside of a few neurogenic niches in the brain, most neurons are fully differentiated and reside in a terminal G0 phase. These fully differentiated neurons form synapses where electrical signals are transmitted by axons to the dendrites of nearby neurons. In this G0 state, neurons continue functioning until senescence or apoptosis. Numerous studies have reported accumulation of DNA damage with age, particularly oxidative damage, in the mammalian brain.[18]

Mechanism of G0 entry

[edit]

Role of Rim15

[edit]

Rim15 was first discovered to play a critical role in initiating meiosis in diploid yeast cells. Under conditions of low glucose and nitrogen, which are key nutrients for the survival of yeast, diploid yeast cells initiate meiosis through the activation of early meiotic-specific genes (EMGs). The expression of EMGs is regulated by Ume6. Ume6 recruits the histone deacetylases, Rpd3 and Sin3, to repress EMG expression when glucose and nitrogen levels are high, and it recruits the EMG transcription factor Ime1 when glucose and nitrogen levels are low. Rim15, named for its role in the regulation of an EMG called IME2, displaces Rpd3 and Sin3, thereby allowing Ume6 to bring Ime1 to the promoters of EMGs for meiosis initiation.[19]

In addition to playing a role in meiosis initiation, Rim15 has also been shown to be a critical effector for yeast cell entry into G0 in the presence of stress. Signals from several different nutrient signaling pathways converge on Rim15, which activates the transcription factors, Gis1, Msn2, and Msn4. Gis1 binds to and activates promoters containing post-diauxic growth shift (PDS) elements while Msn2 and Msn4 bind to and activate promoters containing stress-response elements (STREs). Although it is not clear how Rim15 activates Gis1 and Msn2/4, there is some speculation that it may directly phosphorylate them or be involved in chromatin remodeling. Rim15 has also been found to contain a PAS domain at its N terminal, making it a newly discovered member of the PAS kinase family. The PAS domain is a regulatory unit of the Rim15 protein that may play a role in sensing oxidative stress in yeast.[19]

Nutrient signaling pathways

[edit]

Glucose

[edit]

Yeast grows exponentially through fermentation of glucose. When glucose levels drop, yeast shift from fermentation to cellular respiration, metabolizing the fermentative products from their exponential growth phase. This shift is known as the diauxic shift after which yeast enter G0. When glucose levels in the surroundings are high, the production of cAMP through the RAS-cAMP-PKA pathway (a cAMP-dependent pathway) is elevated, causing protein kinase A (PKA) to inhibit its downstream target Rim15 and allow cell proliferation. When glucose levels drop, cAMP production declines, lifting PKA's inhibition of Rim15 and allowing the yeast cell to enter G0.[19]

Nitrogen

[edit]

In addition to glucose, the presence of nitrogen is crucial for yeast proliferation. Under low nitrogen conditions, Rim15 is activated to promote cell cycle arrest through inactivation of the protein kinases TORC1 and Sch9. While TORC1 and Sch9 belong to two separate pathways, namely the TOR and Fermentable Growth Medium induced pathways respectively, both protein kinases act to promote cytoplasmic retention of Rim15. Under normal conditions, Rim15 is anchored to the cytoplasmic 14-3-3 protein, Bmh2, via phosphorylation of its Thr1075. TORC1 inactivates certain phosphatases in the cytoplasm, keeping Rim15 anchored to Bmh2, while it is thought that Sch9 promotes Rim15 cytoplasmic retention through phosphorylation of another 14-3-3 binding site close to Thr1075. When extracellular nitrogen is low, TORC1 and Sch9 are inactivated, allowing dephosphorylation of Rim15 and its subsequent transport to the nucleus, where it can activate transcription factors involved in promoting cell entry into G0. It has also been found that Rim15 promotes its own export from the nucleus through autophosphorylation.[19]

Phosphate

[edit]

Yeast cells respond to low extracellular phosphate levels by activating genes that are involved in the production and upregulation of inorganic phosphate. The PHO pathway is involved in the regulation of phosphate levels. Under normal conditions, the yeast cyclin-dependent kinase complex, Pho80-Pho85, inactivates the Pho4 transcription factor through phosphorylation. However, when phosphate levels drop, Pho81 inhibits Pho80-Pho85, allowing Pho4 to be active. When phosphate is abundant, Pho80-Pho85 also inhibits the nuclear pool of Rim 15 by promoting phosphorylation of its Thr1075 Bmh2 binding site. Thus, Pho80-Pho85 acts in concert with Sch9 and TORC1 to promote cytoplasmic retention of Rim15 under normal conditions.[19]

Mechanism of G0 exit

[edit]

Cyclin C/Cdk3 and Rb

[edit]

The transition from G1 to S phase is promoted by the inactivation of Rb through its progressive hyperphosphorylation by the Cyclin D/Cdk4 and Cyclin E/Cdk2 complexes in late G1. An early observation that loss of Rb promoted cell cycle re-entry in G0 cells suggested that Rb is also essential in regulating the G0 to G1 transition in quiescent cells.[20] Further observations revealed that levels of cyclin C mRNA are highest when human cells exit G0, suggesting that cyclin C may be involved in Rb phosphorylation to promote cell cycle re-entry of G0 arrested cells. Immunoprecipitation kinase assays revealed that cyclin C has Rb kinase activity. Furthermore, unlike cyclins D and E, cyclin C's Rb kinase activity is highest during early G1 and lowest during late G1 and S phases, suggesting that it may be involved in the G0 to G1 transition. The use of fluorescence-activated cell sorting to identify G0 cells, which are characterized by a high DNA to RNA ratio relative to G1 cells, confirmed the suspicion that cyclin C promotes G0 exit as repression of endogenous cyclin C by RNAi in mammalian cells increased the proportion of cells arrested in G0. Further experiments involving mutation of Rb at specific phosphorylation sites showed that cyclin C phosphorylation of Rb at S807/811 is necessary for G0 exit. It remains unclear, however, whether this phosphorylation pattern is sufficient for G0 exit. Finally, co-immunoprecipitation assays revealed that cyclin-dependent kinase 3 (cdk3) promotes G0 exit by forming a complex with cyclin C to phosphorylate Rb at S807/811. Interestingly, S807/811 are also targets of cyclin D/cdk4 phosphorylation during the G1 to S transition. This might suggest a possible compensation of cdk3 activity by cdk4, especially in light of the observation that G0 exit is only delayed, and not permanently inhibited, in cells lacking cdk3 but functional in cdk4. Despite the overlap of phosphorylation targets, it seems that cdk3 is still necessary for the most effective transition from G0 to G1.[21]

Rb and G0 exit

[edit]

Studies suggest that Rb repression of the E2F family of transcription factors regulates the G0 to G1 transition just as it does the G1 to S transition. Activating E2F complexes are associated with the recruitment of histone acetyltransferases, which activate gene expression necessary for G1 entry, while E2F4 complexes recruit histone deacetylases, which repress gene expression. Phosphorylation of Rb by Cdk complexes allows its dissociation from E2F transcription factors and the subsequent expression of genes necessary for G0 exit. Other members of the Rb pocket protein family, such as p107 and p130, have also been found to be involved in G0 arrest. p130 levels are elevated in G0 and have been found to associate with E2F-4 complexes to repress transcription of E2F target genes. Meanwhile, p107 has been found to rescue the cell arrest phenotype after loss of Rb even though p107 is expressed at comparatively low levels in G0 cells. Taken together, these findings suggest that Rb repression of E2F transcription factors promotes cell arrest while phosphorylation of Rb leads to G0 exit via derepression of E2F target genes.[20] In addition to its regulation of E2F, Rb has also been shown to suppress RNA polymerase I and RNA polymerase III, which are involved in rRNA synthesis. Thus, phosphorylation of Rb also allows activation of rRNA synthesis, which is crucial for protein synthesis upon entry into G1.[21]

References

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia
from Grokipedia
The G0 phase, also known as the quiescent phase, is a distinct stage in the where cells exit the active proliferative cycle and enter a resting or non-replicating state, characterized by 2N content and low metabolic activity for . Unlike the , which involves active preparation for with higher protein content and larger cell size, G0 cells exhibit prolonged arrest before re-entering upon stimulation, typically taking 30-48 hours for the initial transition compared to shorter cycles thereafter. Entry into G0 occurs primarily from the G1 phase in response to nutrient or growth factor deprivation, contact inhibition, or differentiation signals, allowing cells to conserve resources while performing specialized functions. In adult metazoan tissues, the majority of cells reside in G0, either reversibly (as in hepatocytes that regenerate liver tissue after injury or lymphocytes activated by antigens) or permanently (in terminally differentiated cells). This phase is regulated by hypophosphorylated (pRb) and inhibitors such as p21Cip1 and p27Kip1, which repress E2F-mediated transcription of genes required for progression to . Exit from G0 back into G1 is triggered by mitogenic signals, such as those activating cyclin D-cdk4/6 complexes in T lymphocytes via CD3/CD28 stimulation, with a commitment point occurring 3-5 hours post-stimulation. The G0 phase plays a critical role in tissue homeostasis, preventing uncontrolled proliferation while enabling rapid cellular responses to or immune challenges, and its dysregulation is implicated in pathologies like cancer where cells fail to enter quiescence.

Overview and Fundamentals

Definition and Cell Cycle Context

The G0 phase, also known as the quiescent phase, is a distinct state in which cells exit the active , suspending progression through the G1, S, G2, and M phases and thereby halting and . This phase represents a non-proliferative condition where cells can remain either temporarily or permanently, depending on environmental and intrinsic signals. In contrast to the G1 phase, which involves active preparation for DNA synthesis through growth and metabolic upregulation, G0 cells display reduced metabolic activity, including lower ATP levels and diminished oxidative phosphorylation, while maintaining a stable genome without replication-associated risks. Transcriptomic profiles further distinguish G0 from G1, with G0 enriched in genes for stress response, tumor suppression, and epigenetic maintenance rather than proliferation regulators like cyclins and E2F targets. The G0 phase primarily enables cells to conserve energy during nutrient scarcity or stress, adapt to external cues, and commit to specialization without ongoing division, thereby supporting tissue and . This state was first characterized in the through studies on serum-starved mammalian fibroblasts, which enter quiescence upon withdrawal; in contrast, yeast models exhibit G0 as a nutrient-induced , where halts and division prior to the G1 commitment point.31268-8)

Historical Discovery and Key Observations

The concept of the G0 phase emerged in the 1960s from kinetic analyses of hematopoietic cells, where Laszlo G. Lajtha proposed a quiescent resting state to explain why only a small fraction of bone marrow stem cells were actively proliferating at any given time. Lajtha's model, based on isotope labeling experiments, described G0 as an extension of G1 where cells could exit the cycle indefinitely, awaiting stimulatory signals to re-enter proliferation or differentiate, thus accounting for tissue homeostasis in non-dividing populations. This discovery built on earlier cell cycle definitions by Howard and Pelc (1953) but introduced the idea of a reversible non-cycling compartment essential for stem cell maintenance. In the 1970s, studies on cultured fibroblasts extended these observations to mitogen-responsive systems, demonstrating that serum-starved cells, such as Swiss 3T3 lines, entered G0 upon withdrawal, exhibiting sharply reduced rates of and . Arthur B. Pardee's identification of the in 1974 was pivotal, revealing a late G1 checkpoint beyond which cells commit to ; cells encountering deprivation before this point diverted into G0, linking environmental cues directly to quiescence entry. Autoradiographic techniques with tritiated confirmed these findings by showing minimal label incorporation in G0 cells, distinguishing them from cycling G1 populations through low proliferative activity. Analogous arrest states were noted in model organisms, such as sporulation, where diploid cells halted in a G1-like phase prior to , providing an early experimental parallel for G0 regulation. By the 1980s, enabled quantitative validation of G0 as a distinct state, with pioneering work by Darzynkiewicz and colleagues resolving G0 from G1 based on lower content and proliferation markers in quiescent populations. pulse-chase labeling experiments further substantiated that G0 cells failed to enter even after prolonged exposure, reinforcing the phase's role in stable arrest. In the , molecular insights solidified these observations when Polyak et al. cloned p27Kip1, a inhibitor upregulated in mitogen-starved cells to enforce G0 entry by blocking G1 progression. This inhibitor's accumulation in quiescent fibroblasts provided a mechanistic basis for the historical kinetic data, marking a transition from descriptive to regulatory understanding of G0.

Diversity and Types of G0 States

Reversible versus Irreversible Quiescence

The G0 phase encompasses distinct forms of cellular quiescence, classified primarily by their potential for re-entry into the cell cycle. Reversible quiescence represents a temporary arrest in which cells maintain their proliferative capacity and can resume cycling upon appropriate stimuli, such as growth factors or nutrient availability. This state allows cells to pause proliferation while preserving the ability to respond to environmental cues, with durations varying widely from hours, as seen in short-term serum deprivation experiments, to years in long-lived populations like adult stem cells. In contrast, irreversible quiescence involves a permanent withdrawal from the , typically associated with terminal differentiation or , where cells establish stable barriers to re-proliferation. These barriers often include persistent epigenetic modifications that lock the in a non-permissive configuration for cycle re-entry, rendering the state enduring and non-responsive to standard mitogenic signals. Unlike reversible forms, this arrest serves as a programmed endpoint, preventing further division to maintain specialized functions or limit . Key distinctions between these states lie in their functional implications and measurable outcomes. Reversibility is often quantified by re-entry efficiency, where reversible G0 cells exhibit high rates of cycle resumption upon appropriate compared to little to no re-entry in irreversible cases, reflecting the absence of viable proliferative potential. Both states feature a proliferation index (PI), defined as the ratio of cycling cells (in S + G2/M phases) to total cells, approaching zero due to G0 dominance; however, reversible quiescence permits PI recovery upon perturbation, whereas irreversible forms do not. Conceptually, reversible quiescence functions as an adaptive mechanism for tissue , enabling rapid mobilization during repair or growth demands, while irreversible quiescence acts as a terminal safeguard against uncontrolled proliferation or dysfunction.

Variations Across Cell Types and Organisms

The G0 phase manifests distinctly across organisms, reflecting adaptations to environmental stresses and developmental needs. In unicellular , non-growing persister cells enter a dormant state analogous to quiescence, enabling survival during antibiotic exposure or nutrient scarcity without genetic resistance. In the unicellular Saccharomyces cerevisiae, G0 corresponds to the stationary phase triggered by nutrient depletion, where cells arrest proliferation but maintain metabolic activity for prolonged viability. By contrast, in multicellular mammals, G0 typically represents a reversible quiescence responsive to mitogenic signals, such as serum growth factors that stimulate quiescent fibroblasts to re-enter the . Variations also arise among mammalian cell types, influenced by lineage-specific functions. Hematopoietic and neural stem cells often exhibit deep G0 quiescence characterized by slow cycling, which preserves long-term self-renewal potential while minimizing replication errors. Neurons, upon terminal differentiation, enter an irreversible post-mitotic G0 state, withdrawing permanently from the to prioritize synaptic maintenance over division. The duration of G0 differs markedly; for instance, fibroblasts can sustain reversible G0 for hours to days under serum starvation before mitogen-induced exit, whereas cardiomyocytes remain in a lifelong, permanent G0 arrest postnatally, limiting heart regeneration. Evolutionarily, G0-like arrests likely originated in unicellular organisms as a survival mechanism against starvation or toxins, with multicellular lineages adapting this quiescence for tissue development, repair, and specialization—such as coordinating proliferation with differentiation in metazoans. Recent studies highlight analogous states in plants and invertebrates: in seeds, G0 quiescence underlies dormancy, as seen in transcriptomic shifts from radicle dormancy (G0) to germination activation, ensuring survival until favorable conditions. In the nematode Caenorhabditis elegans, the dauer larval stage induces a stress-resistant quiescence akin to G0, halting development under adverse cues like overcrowding to promote longevity. These organismal and cellular diversities underscore G0's role in balancing survival, homeostasis, and evolutionary fitness.

Molecular Characteristics of Quiescent Cells

Transcriptomic and Epigenetic Features

Quiescent cells in the G0 phase exhibit distinct transcriptomic profiles characterized by the downregulation of genes promoting progression, such as MYC and CCND1, which facilitates the exit from active proliferation. Concurrently, quiescence markers including CDKN1B (encoding p27Kip1) are upregulated, enforcing cell cycle arrest through inhibition of cyclin-dependent kinases. In populations, G0 transcriptomes show enrichment for genes, alongside factors that promote survival, which collectively support genomic stability and prolonged quiescence. Epigenetic landscapes in G0 cells feature expanded domains, marked by increased deposition at promoters of proliferation-associated genes, which represses their transcription and sustains the quiescent state. DNA hypermethylation at CpG islands of regulators further reinforces this silencing, preventing ectopic activation. Additionally, incorporation of the variant macroH2A into nucleosomes stabilizes compacted structures, contributing to the durable repression observed in quiescent cells. Bulk analyses from the 2010s have identified G0-specific clusters, demonstrating significant changes in the compared to cells, including overall mRNA level reductions to approximately 30%, with prominent downregulation of metabolic and biosynthetic pathways. Complementary ChIP-seq studies map these changes to epigenetic modifications, revealing enriched and reduced at proliferation loci in quiescent populations. Single-cell data from the 2020s further uncover heterogeneous G0 subclusters within tissues, such as varying depths of quiescence in neural and hematopoietic stem cells, highlighting transcriptional diversity that correlates with functional states.

Metabolic and Structural Changes

During entry into the G0 phase, cells undergo pronounced metabolic reprogramming to prioritize survival and over proliferation. and (OXPHOS) are significantly downregulated, with quiescent fibroblasts and lymphocytes exhibiting reduced and mitochondrial activity to minimize energy expenditure. This shift is evident in hematopoietic stem cells (HSCs), where low OXPHOS maintains a hypoxic-like state with fewer mitochondria, preventing (ROS) accumulation. Concurrently, is upregulated as a primary mechanism for nutrient recycling, enabling cells to degrade and reutilize intracellular components during nutrient scarcity. Lysosomal activity intensifies to support autophagic flux, with quiescent HSCs displaying enlarged lysosomes that facilitate protein and breakdown. Amino acid becomes dominant, as autophagy-derived are oxidized for energy, a process critical for sustaining quiescence in and mammalian models. Structurally, G0 cells exhibit adaptations that reflect their dormant state. Nucleoli diminish in size and activity, correlating with suppressed synthesis observed in stationary-phase and quiescent fibroblasts via electron microscopy. condenses into a more compact configuration, visible as heterochromatic regions under electron microscopy in G0-arrested cells, which restricts transcription and preserves genomic integrity. Cytoskeletal elements reorganize to reduce cellular ; for instance, stabilization and primary formation occur in quiescent fibroblasts and stem cells, limiting dynamic remodeling and signaling for proliferation. Lysosome biogenesis ramps up, leading to increased numbers and size, which supports degradative processes without triggering activation. These metabolic and structural alterations confer functional advantages, including robust with reduced ATP levels due to suppressed and biosynthetic demands, as seen across quiescent cell types. The resulting altered balance, characterized by lowered ROS production, enhances resistance to and , allowing prolonged survival in harsh environments. Recent studies from the 2020s have revealed G0-specific accumulation of droplets as storage reservoirs; in quiescent neural stem/progenitor cells, these droplets enlarge and increase in number, serving as lipid reserves for potential rapid mobilization upon G0 exit.

Regulation of Quiescence

Cell Cycle Inhibitors and Regulators

The maintenance of the G0 phase relies heavily on (CDK) inhibitors, which prevent the by binding to and inhibiting CDK complexes. The Cip/Kip family members, including p21Cip1, p27Kip1, and p57Kip2, associate with E/CDK2 and /CDK4/6 complexes to block their activity, thereby enforcing arrest in quiescent states. These inhibitors accumulate in response to various cues, stabilizing the hypoproliferative state characteristic of G0. Members of the (Rb) protein family—pRb, , and p130—play a central role in G0 regulation by sequestering transcription factors, which are essential for activating genes required for S-phase entry. In quiescent cells, these Rb family proteins exist in a hypophosphorylated form, enabling them to form repressive complexes such as the DREAM complex (involving or p130 with 4/5), which silences promoters. This hypophosphorylation reverses the hyperphosphorylated state of proliferating cells, reinforcing quiescence. Positive regulators of quiescence further enhance inhibitor expression to sustain G0. FOXO transcription factors, such as FOXO3a, directly induce p27Kip1 transcription, promoting cell cycle arrest in hematopoietic stem cells and other quiescent populations. Similarly, TGF-β signaling upregulates p15Ink4b, an INK4 family that specifically targets CDK4/6 to inhibit cyclin D-dependent progression. The dynamics of G0 maintenance follow a , wherein the accumulation of these inhibitors surpasses the levels of activating complexes like /CDK4/6, tipping the balance toward repression. This imbalance ensures stable hypophosphorylation of Rb family proteins, preventing E2F release and S-phase . In the context of senescence-linked G0, an irreversible form of quiescence often observed in cancer studies, the INK4/ARF locus amplifies inhibition through p16Ink4a (which blocks CDK4/6) and p14ARF (which stabilizes to induce p21Cip1). Research since the 2010s highlights how locus activation in premalignant cells enforces oncogene-induced , suppressing tumorigenesis by locking cells in a permanent G0-like . Post-transcriptional regulation, such as miRNAs stabilizing p27Kip1, can further reinforce these inhibitory networks in quiescent cells. Recent advances (as of 2025) have identified additional regulators, such as G0S2, which modulates to sustain quiescence, and 3D reorganization in hematopoietic stem cells that reinforces G0 entry during stress.

Nutrient and Stress Signaling Pathways

Nutrient signaling pathways play a central role in modulating entry into and maintenance of the G0 phase by integrating environmental cues with cellular growth decisions. In response to low levels of or glucose, the target of rapamycin complex 1 (TORC1) pathway is inhibited, leading to reduced protein synthesis and promotion of quiescence in both and mammalian cells. This inhibition allows cells to conserve resources during nutrient scarcity, facilitating a reversible arrest in G0. Similarly, (AMPK) activation senses energy depletion through elevated AMP/ATP ratios, phosphorylating downstream targets to halt anabolic processes and enforce quiescence, as observed with its yeast homolog Snf1 under glucose limitation and with AMPK in mammalian cells during caloric restriction. Withdrawal of insulin or insulin-like growth factor-1 (IGF-1) signaling further promotes G0 entry by diminishing PI3K-AKT pathway activity, which normally drives proliferation; this is evident in hematopoietic stem cells where reduced IGF-1 maintains quiescence to preserve long-term repopulation potential. Stress signaling pathways respond to cellular insults by triggering G0 arrest to prevent propagation of damage. DNA damage activates p53, which transcriptionally upregulates p21 (CDKN1A), a inhibitor that enforces quiescence and allows , particularly in hematopoietic s during steady-state conditions. engages the nuclear factor erythroid 2-related factor 2 (NRF2) pathway, where NRF2 translocation to the nucleus induces antioxidant genes, enhancing survival and maintaining quiescence in stem cells exposed to , thereby protecting against depletion in aging tissues. Hypoxia-inducible factors (HIFs), stabilized under low oxygen, promote G0 stabilization in stem cell niches; for instance, HIF-1α accumulation in hypoxic environments sustains quiescence in hematopoietic stem cells by modulating glycolytic and limiting proliferation. These pathways exhibit extensive , where scarcity amplifies stress responses to coordinate quiescence. The TOR-AMPK axis exemplifies this integration, as AMPK directly inhibits TORC1 under stress, suppressing growth signals and reinforcing G0 entry across eukaryotes; in , this involves Sch9 (a TORC1 effector analogous to mammalian S6 ), while in mammals, it extends to maintenance. Recent studies highlight additional influences from the , where (SCFAs) produced by gut bacteria, such as butyrate, modulate intestinal quiescence; in models, SCFAs inhibit proliferation and promote G0-like states by altering Wnt signaling and metabolic profiles, underscoring microbial impacts on epithelial regeneration in the 2020s.

Mechanisms of G0 Entry

Nutrient-Dependent Pathways

In , glucose sensing primarily occurs through the cAMP-dependent (PKA) and target of rapamycin (TOR) pathways, where low glucose levels lead to inactivation of both signaling cascades, promoting arrest in G0. This inhibition reduces anabolic processes and triggers metabolic reprogramming, including the accumulation of as a storage , which supports cellular survival during nutrient scarcity. Additionally, reduced glucose flux diminishes activity in the hexosamine biosynthetic pathway, lowering O-linked β-N-acetylglucosamine (O-GlcNAc) modification of proteins, which helps maintain the quiescent state by limiting proliferative signaling. Nitrogen and amino acid availability are monitored via pathways that curtail protein synthesis upon limitation, facilitating G0 entry. In response to amino acid starvation, accumulation of uncharged transfer RNAs activates the kinase GCN2, which phosphorylates eukaryotic initiation factor 2α (eIF2α), thereby attenuating global translation while selectively enhancing stress-response gene expression. Specific amino acids like leucine further contribute by inhibiting mTORC1 through Rag GTPase-mediated mechanisms, suppressing growth signals and promoting quiescence. Phosphate sensing in involves the Pho80-Pho85 (CDK) complex, which is inhibited by the Pho81 under low-phosphate conditions, leading to of transcription factors and arrest in G0. These pathways often integrate with stress signals, such as oxidative damage, to fine-tune G0 commitment under combined nutrient and environmental pressures.

Role of Key Effectors like Rim15

In , Rim15 functions as a key that integrates nutrient signaling pathways to facilitate entry into the G0 phase of quiescence. Activated primarily through the inhibition of TORC1, PKA, and Sch9 kinases under nutrient-limiting conditions, Rim15 undergoes at sites such as Thr1075, enabling its nuclear translocation and subsequent of downstream targets that promote stress responses and arrest in G1. Deletion mutants of RIM15 (rim15Δ) display severe defects in G0 establishment, including failure to accumulate protective metabolites like and , reduced resistance to , and inability to properly arrest the , leading to continued proliferation under . The mechanism of Rim15 involves coordination of transcriptional and post-transcriptional events to activate quiescence-specific . In the nucleus, Rim15 enhances the activity of transcription factors Msn2 and Msn4, which bind stress response elements (STRE) to induce genes involved in defense, synthesis, and inhibition; it also supports Gis1-dependent post-diauxic shift genes for metabolic reprogramming. This orchestration ensures G0 entry kinetics align with nutrient depletion signals, with nuclear accumulation and initial induction observable within 2-4 hours post-shift to media, preceding full stationary phase adaptation. Recent phosphoproteomic studies have further elucidated Rim15's role, revealing its discrete targets in metabolism and control that converge with other TORC1 effectors to fine-tune the quiescence program during . Functional equivalents of Rim15 exist in mammals, where kinases like GSK3β exhibit conserved roles in promoting quiescence by integrating stress and nutrient cues. In quiescent CD4+ T cells and , GSK3β maintains cell cycle exit through transcriptional repression of proliferation genes via inhibition of CREB, , and AP-1, while also facilitating FOXO nuclear localization in response to low growth factor signaling, thereby enhancing FOXO-dependent expression of cell cycle inhibitors like p27Kip1. Similarly, SGK1, a stress-induced kinase, supports quiescence maintenance in epithelial and immune cells by modulating mitochondrial ATP synthesis and FOXO activity under oxidative or stress conditions. These mammalian effectors highlight cross-kingdom conservation of Rim15-like mechanisms, where kinase-mediated signal integration ensures reversible G0 arrest for survival and regeneration. Recent advances, including 2022 studies on Rim15 by C-Cdk8, underscore its broader regulatory network in responses, expanding understanding beyond to potential therapeutic parallels in mammalian quiescence disorders.

Mechanisms of G0 Exit

Cyclin-Dependent Kinase Activation

The exit from the G0 phase into the is critically dependent on the activation of (CDK) complexes, which phosphorylate key substrates to dismantle quiescence-maintaining barriers. These kinases form heterodimers with regulatory cyclins, whose oscillatory expression patterns dictate phase-specific activity, ensuring ordered progression from G0 to G1 and beyond. Central to G0 exit are the /CDK4/6 complexes, which initiate the process by phosphorylating the (Rb) at select sites, partially relieving its repression of transcription factors. This is followed by Cyclin E/CDK2 and Cyclin A/CDK2 complexes, which drive hyperphosphorylation of Rb, fully releasing E2Fs to transcribe genes required for and S-phase entry. Activation of these complexes begins with mitogen-induced transcription of cyclin genes; for instance, growth factors like PDGF trigger rapid expression via MAPK/ERK signaling, assembling active CDK4/6 within hours of stimulation. Full enzymatic activity further requires phosphorylation by CDK-activating kinase (CAK, often CDK7/cyclin H/MAT1), which targets the T-loop (e.g., Thr160 in CDK2), stabilizing the active conformation and enhancing substrate affinity. The dynamics of CDK activation exhibit switch-like behavior, characterized by threshold-dependent multi-site phosphorylation of Rb at 8-10 conserved CDK consensus sites (e.g., Ser/Thr-Pro motifs in the Rb pocket and C-terminal domains), which collectively inactivate Rb's repressive function. Post-mitogen stimulation in quiescent cells, such as fibroblasts, the initial CDK activity spike—driven by /CDK4/6—emerges within 1-2 hours, escalating to peak E/CDK2 activity by 6-8 hours to commit cells past the .

Retinoblastoma Protein Dynamics

In quiescent cells during the G0 phase, the (Rb) exists in a hypophosphorylated state that enables it to bind and inhibit /DP complexes, thereby repressing the expression of S-phase genes essential for progression. This repression maintains cellular quiescence by preventing the transcription of targets such as cyclins E and A, DNA polymerase subunits, and other proliferation-associated genes. Upon exposure to mitogenic signals, cyclin-dependent kinases (CDKs) phosphorylate Rb at multiple sites, leading to its hyperphosphorylation and dissociation from ; this releases to activate transcription and facilitate G0 exit into the . Rb family members p107 and p130 play dominant roles in G0 quiescence, often forming repressive complexes with that target distinct gene sets compared to Rb. In particular, p130 associates predominantly with promoters in G0 cells to enforce long-term quiescence maintenance, repressing genes involved in re-entry more effectively than Rb in this phase. These pocket proteins exhibit functional redundancy but specialized contributions, with and p130 complexes being more abundant in resting states to sustain transcriptional silencing. Following Rb hyperphosphorylation and release, loops amplify G0 exit through auto-activation, where freed transcription factors bind to their own promoters and those of downstream targets, creating a bistable switch that commits cells to proliferation. In cancer, loss of Rb function disrupts this gating mechanism, allowing cells to bypass G0 arrest and evade therapies that rely on inducing quiescence, such as CDK4/6 inhibitors, thereby promoting resistance and tumor progression. Recent structural studies in the 2020s have elucidated the Rb- interface at atomic resolution, revealing dual inhibitory contacts—via the Rb pocket domain and a marked box—that must be sequentially disrupted for full E2F activation during G0 exit. These insights highlight how alters conformational dynamics at the interface, providing a molecular basis for therapeutic modulation. Additionally, Rb enable escape from senescence-associated G0-like states by derepressing E2F targets like E1, allowing proliferation in otherwise arrested cells and contributing to oncogenesis.

Biological Examples and Implications

Reversible G0 in Stem and Regenerative Cells

In tissue stem cells, the G0 phase serves as a reversible state of quiescence that preserves proliferative potential for long-term tissue maintenance. Hematopoietic stem cells (HSCs) predominantly reside in G0, maintained by transforming growth factor β (TGF-β) signaling, which inhibits cell cycle progression and promotes dormancy to protect against exhaustion during steady-state hematopoiesis. These dormant HSCs cycle infrequently, dividing approximately every 145 days based on computational modeling of label-retention data. Similarly, neural stem cells in the adult (SVZ) exhibit high quiescence, with the majority—estimated at around 80-90%—remaining in G0 to balance with self-renewal and prevent premature depletion of the pool. Mature hepatocytes represent another key example of cells capable of reversible G0 entry and exit, enabling robust . Following normal division, these polyploid cells re-enter G0 as a quiescent state, poised for activation upon injury. In models of 70% partial , interleukin-6 (IL-6) signaling via the JAK/ pathway rapidly induces exit from G0, driving the G0-to-G1 transition and subsequent proliferation to restore liver mass within days. This process highlights the regenerative competence of quiescent hepatocytes, which differ from true stem cells but share functional similarities in their ability to re-enter the efficiently. The implications of reversible G0 extend to preventing exhaustion and maintaining tissue , as quiescence shields cells from replicative stress and damage accumulation. Label-retaining cells (LRCs), identified through techniques like BrdU pulse-chase labeling, predominantly occupy G0 and mark quiescent reservoirs in various tissues, including the hematopoietic system and , where they serve as a reserve for regeneration. Recent advances, such as 2020s CRISPR-Cas9 screens in intestinal organoids derived from stem cells, have identified regulators like Smarca4 and Smarcc1 that influence cell fate decisions during epithelial maturation, underscoring the molecular control in proliferative-competent populations.

Irreversible G0 in Terminally Differentiated and Senescent Cells

In terminally differentiated cells, such as myotubes, neurons, and osteocytes, the G0 phase represents a permanent exit from the cell cycle, enabling specialized functions while preventing proliferation. In skeletal muscle, the transcription factor MyoD drives terminal differentiation by upregulating the cyclin-dependent kinase inhibitor p21, which inhibits CDK activity and enforces irreversible cell cycle arrest. This mechanism ensures that multinucleated myotubes maintain contractile function without risking uncontrolled division. Similarly, in neurons, the repressor element-1 silencing transcription factor (REST/NRSF) maintains the post-mitotic state by binding to neuron-restrictive silencer elements in the promoters of cell cycle genes, such as cyclins and CDKs, thereby silencing their expression and preventing re-entry into the cell cycle. In bone tissue, Runx2, a master regulator of osteoblast differentiation, couples terminal maturation of osteocytes to cell cycle withdrawal by inducing p27Kip1 expression, which inhibits S-phase progression and promotes hypophosphorylated retinoblastoma protein (pRb) activity to lock cells in G0. Senescent cells also enter an irreversible as a response to persistent stressors, including erosion from repeated replication or -induced hyperproliferation. shortening activates a damage response, leading to stable arrest through /p21 and INK4a pathways, without reliance on reactivation. stress, such as RAS activation, similarly triggers by generating replication fork stalling and damage, enforcing G1 arrest via ARF-mediated activation and INK4a upregulation. The (SASP), characterized by secretion of proinflammatory cytokines like IL-6 and IL-8, further sustains this arrest by reinforcing INK4a/Rb signaling in an autocrine manner, while also contributing to tissue remodeling and immune surveillance. Mechanisms underlying this irreversibility in both differentiated and senescent cells often involve epigenetic silencing of CDK genes and E2F targets, mediated by Rb-mediated chromatin compaction and histone modifications that prevent mitogen-induced re-entry. In post-mitotic neurons, for instance, exposure to mitogens in vitro fails to induce proliferation, with re-entry attempts typically leading to apoptosis rather than division, as evidenced by near-complete resistance to cell cycle reactivation. This non-reversibility extends to other tissues; senescent adipocytes in aging adipose tissue exhibit persistent G0 arrest linked to oxidative stress and inflammation, impairing lipid storage and contributing to metabolic dysfunction. Likewise, immunosenescent T cells in the aging immune system display irreversible quiescence with upregulated p16INK4a and SASP factors, reducing adaptive immunity and promoting chronic inflammation. Recent therapeutic advances in the 2020s have targeted this irreversible G0 state with senolytics to alleviate aging-related burdens in tissues. For example, polyphenol-based senolytics like Haenkenium have reduced markers in aged mouse models, improving health span by selectively clearing senescent cells in vascular and hematopoietic tissues. Antibody-drug conjugates targeting surface markers such as β2-microglobulin have also shown promise in eliminating senescent populations without broad , highlighting potential interventions for age-associated tissue dysfunction.

References

Add your contribution
Related Hubs
User Avatar
No comments yet.